Using FHIR to Support COVID-19 Vaccine Safety Electronic Case Reports in America
Daniel A. Rizzato Lede, Helvert F. Molina, Maria Paz Bertoglia, Daniel Otzoy, Luis A. Benavides, José A. Donis, Víctor B. Osorio, Carlos Aguilar, José L. Bustos, Martín Diaz, Karina Revirol, César Galindo, Jorge Mansilla, Fernando Campos, Diego Kaminker, Marcelo D’agostino, Desiree Pastor
During the COVID-19 pandemic, the Pan American Health Organization (PAHO) promoted several activities to strengthen the countries’ emergency response. Vaccines represented a breakthrough in the pandemic evolution, even though they have not been equitably distributed. As most vaccines have received emergency authorizations for their timely delivery, vaccine safety surveillance has been highlighted for detecting early signals of potential adverse events following immunization (AEFI, also known as ESAVI). The objective of this article is to share the different steps, methodologies, and preliminary results of a regional policy to strengthen the ESAVI surveillance system in the Americas, including the adoption of HL7 FHIR for health information exchange between countries and PAHO.
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
Tel.: +1 703 830 6300
Fax: +1 703 830 2300 email@example.com
(Corporate matters and books only) IOS Press c/o Accucoms US, Inc.
For North America Sales and Customer Service
West Point Commons
Lansdale PA 19446
Tel.: +1 866 855 8967
Fax: +1 215 660 5042 firstname.lastname@example.org